BCRX R&D Expenses

Biocryst Pharmaceuticals Inc · R&D Expenses

BCRX logo

BCRX R&D Expenses

Latest reported$197.76M
BCRX TTM R&D Expenses ($0.00 → $197.76M)
High-resolution chart · PNG

BCRX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
197,758,000
189,175,000
166,126,000
174,365,000
171,178,000
165,415,000
174,638,000
195,249,000
201,047,000
214,671,000
216,566,000
219,721,000
225,582,000
236,325,000
253,297,000
243,619,000
240,850,000
231,733,000
208,808,000
180,633,000
160,907,000
135,532,000
122,964,000
114,384,000
109,259,000
109,442,000
107,068,000
103,725,000
100,611,000
93,940,000
84,888,000
78,381,000
73,884,000
68,633,000
66,962,000
62,196,000
58,792,000
57,199,000
61,008,000
67,897,000
73,859,000
76,217,000
72,758,000
72,221,000
65,190,000
59,733,000
51,796,000
48,900,000
43,841,000
44,502,000
42,730,000
38,206,000
42,301,000
43,350,000
51,380,000
55,501,000
58,201,000
59,399,000
56,890,000
65,301,014
69,726,014
70,488,014
82,473,014
90,469,442
89,453,442
85,929,442
72,301,442
62,742,634
60,557,634
62,717,634
73,326,634
80,380,996
94,114,996
99,754,996
94,051,996
76,137,372
63,057,372
55,234,372
47,082,372
41,923,377
32,437,377
26,510,377
23,642,377
22,302,112
19,976,112
19,061,112
18,869,112
17,132,000
15,399,000
14,016,000
11,522,000
11,097,491
11,164,491
12,576,491
15,474,491
17,954,057
17,612,057
15,949,057
13,092,057
10,988,352
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.